HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hypoparathyroidism — Clinical Guidelines

Overview

Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and low or inappropriately normal parathyroid hormone (PTH) levels, often resulting from surgical damage, genetic causes, or autoimmune conditions 1 3.

Diagnosis

Key Diagnostic Criteria: Hypocalcemia with low or normal PTH levels 3.

Recommended Tests: Serum calcium, ionized calcium, PTH levels, and phosphorus levels 3.

Additional Assessments: Imaging studies (e.g., ultrasound of parathyroid glands) if surgical etiology is suspected 1.

Management

First-Line Treatments:

- Vitamin D Analogs: Alfacalcidol or calcitriol to correct hypocalcemia 5 15. - Calcium Supplementation: Oral calcium to maintain serum calcium levels 1 15.

Adjunctive Treatments:

- Recombinant Human PTH(1-84): For patients requiring more precise calcium control 11. - Monitoring: Regular monitoring of serum calcium, phosphorus, and PTH levels 2 15.

Special Populations

Pediatrics: Treatment with high-dose vitamin D (ergocalciferol, D2, and cholecalciferol) is common 13.

Elderly: Increased vigilance for complications like cardiac dysfunction and cognitive impairment 26 32.

Comorbidities: Consider interactions, e.g., alendronate unmasking hypoparathyroidism 17.

Key Recommendations

Initiate treatment with activated vitamin D analogs (alfacalcidol or calcitriol) and calcium supplementation to manage hypocalcemia (Evidence: Strong 5 15).

Regular monitoring of serum calcium, phosphorus, and PTH levels is essential for effective management (Evidence: Strong 2 15).

Consider recombinant human PTH(1-84) for patients with persistent hypocalcemia despite conventional therapy (Evidence: Moderate 11).

Patients should be educated on recognizing and managing acute hypocalcemic crises (Evidence: Expert opinion 9).

In pediatric cases, high-dose vitamin D therapy should be considered (Evidence: Moderate 13).

References

1 Misiorowski W, Kos-Kudła B, Hubalewska-Dydejczyk A, Ruchała M, Zgliczyński W, Zygmunt A et al.. Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026. Endokrynologia Polska 2026. link 2 Bollerslev J, Buch O, Cardoso LM, Gittoes N, Houillier P, van Hulsteijn L et al.. Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults. European journal of endocrinology 2025. link 3 Kassi E, Adamidou F, Yavropoulou MP, Anastasilakis AD, Makras P, Vryonidou A et al.. Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society. Hormones (Athens, Greece) 2025. link 4 Khan AA, Ali DS, Bilezikian JP, Björnsdottir S, Collins MT, Cusano NE et al.. Best practice recommendations for the diagnosis and management of hypoparathyroidism. Metabolism: clinical and experimental 2025. link 5 Stuss M, Michalska-Kasiczak M, Sewerynek E. Clinical efficacy and safety of use of alfacalcidol and calcitriol in daily endocrinological practice. Endokrynologia Polska 2023. link 6 Cipriani C, Cianferotti L. Vitamin D in hypoparathyroidism: insight into pathophysiology and perspectives in clinical practice. Endocrine 2023. link 7 . EASL Clinical Practice Guidelines on haemochromatosis. Journal of hepatology 2022. link 8 Hum RM, Ho P. Hereditary haemochromatosis presenting to rheumatology clinic as inflammatory arthritis. BMJ case reports 2022. link 9 Astor MC, Zhu W, Björnsdottir S, Bollerslev J, Kämpe O, Husebye ES. Is there a need for an emergency card in hypoparathyroidism?. Journal of internal medicine 2019. link 10 Sauer N, Lautenbach A, Pohl K, Schön G, Brose HP, Schulze Zur Wiesch CA et al.. Screening and management of postoperative hypoparathyroidism-induced hypocalcemia in thyroidectomized patients in the endocrine ward compared with the surgical ward. Ear, nose, & throat journal 2018. link 11 Tabacco G, Bilezikian JP. New Directions in Treatment of Hypoparathyroidism. Endocrinology and metabolism clinics of North America 2018. link 12 Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S et al.. HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy. Calcified tissue international 2018. link 13 Di Maio S, Soliman AT, De Sanctis V, Kattamis CC. Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents. Acta bio-medica : Atenei Parmensis 2018. link 14 Illeez Memetoglu O, Unlu Ozkan F, Taraktas A, Aktas I, Nazikoglu C. Idiopathic Hypoparathyroidism Mimicking Ankylosing Spondylitis: A Case Report. Acta reumatologica portuguesa 2016. link 15 Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W et al.. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. European journal of endocrinology 2015. link 16 Pal K. Sanjad-Sakati syndrome in a neonate. Indian pediatrics 2010. link 17 Kashyap AS, Kashyap S. Hypoparathyroidism unmasked by alendronate. Postgraduate medical journal 2000. link 18 Sari R, Yildirim B, Sevinc A, Buyukberber S. Idiopathic hypoparathyroidism and celiac disease in two patients with previous history of cataract. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2000. link 19 Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. Journal of hepatology 2000. link80415-8) 20 Boots JM, Burghouts JT, Jansen JL. Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol. The Netherlands journal of medicine 1999. link00133-8) 21 Schilling T, Ziegler R. Current therapy of hypoparathyroidism--a survey of German endocrinology centers. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1997. link 22 Soliman AT, Darwish A, alSalmi I, Asfour M. Defective growth hormone secretion and hypogonadism in the new syndrome of congenital hypoparathyroidism, growth failure and dysmorphic features. Indian journal of pediatrics 1996. link 23 Hershkovitz E, Shalitin S, Levy J, Leiberman E, Weinshtock A, Varsano I et al.. The new syndrome of congenital hypoparathyroidism associated with dysmorphism, growth retardation, and developmental delay--a report of six patients. Israel journal of medical sciences 1995. link 24 Sanjad SA, Sakati NA, Abu-Osba YK, Kaddoura R, Milner RD. A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features. Archives of disease in childhood 1991. link 25 Menahem S, Salmon AP, Dennett X. Haemochromatosis presenting as severe cardiac failure in a young adolescent. International journal of cardiology 1990. link90278-d) 26 Csanády M, Forster T, Julesz J. Reversible impairment of myocardial function in hypoparathyroidism causing hypocalcaemia. British heart journal 1990. link 27 Abbott M, Galloway A, Cunningham JL. Haemochromatosis presenting with a double Yersinia infection. The Journal of infection 1986. link92869-0) 28 Uncini A, Tartaro A, Di Stefano E, Gambi D. Parkinsonism, basal ganglia calcification and epilepsy as late complications of postoperative hypoparathyroidism. Journal of neurology 1985. link 29 Levine DF. Hypocalcaemia increases the narcotic effect of codeine. Postgraduate medical journal 1980. link 30 Walters RO. Idiopathic hypoparathyroidism with extrapyramidal and myopathic features. Archives of disease in childhood 1979. link 31 Slyter H. Idiopathic hypoparathyroidism presenting as dementia. Neurology 1979. link 32 Brenton DP, Gonzales J, Pollard AB. Hypocalcaemic cardiac failure. Postgraduate medical journal 1978. link 33 Farup PG. Idiopathic Hypoparathyroidism and Hyperthyroidism. Acta medica Scandinavica 1977. link 34 Waisman M, O'Regan S. Maculopapular eruption in hypoparathyroidism. Archives of dermatology 1976. link

Hypoparathyroidism